The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday.

The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy.

“It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also open up other innovation,” said Amy Emerson, CEO of MAPS Public Benefit Corporation, the research sponsor.

  • ryathal
    link
    fedilink
    arrow-up
    1
    arrow-down
    5
    ·
    1 year ago

    Decriminalization of psychedelics and medical treatment are opposite ends of the spectrum.

    • treefrog@lemm.ee
      link
      fedilink
      arrow-up
      3
      arrow-down
      1
      ·
      1 year ago

      Not really.

      A drug war that criminalized medicine that Dr’s where researching and that people were enjoying for both personal exploration and recreation is the opposite end of the spectrum.